References
- BennettSRFolkJCBlodiCFKlugmanMFactors prognostic of visual outcome in patients with subretinal hemorrhageAm J Ophthalmol1990109133372297030
- ChanWMLiuDTLaiTYLiHTongJPLamDSExtensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow upClin Experiment Ophthalmol200533661161816402954
- AveryRLFekratSHawkinsBSBresslerNMNatural history of subfoveal subretinal hemorrhage in age-related macular degenerationRetina19961631831898789855
- BerrocalMHLewisMLFlynnHWJrVariations in the clinical course of submacular hemorrhageAm J Ophthalmol199612244864938862044
- SaitoKIijimaH[Visual prognosis and macular pathology in eyes with retinal macroaneurysms]Nippon Ganka Gakkai Zasshi19971012148151 Japanese9124095
- IbanezHEWilliamsDFThomasMASurgical management of submacular hemorrhage. A series of 47 consecutive casesArch Ophthalmol1995113162697826295
- ChenWLLiuJHLeeFLNatural course of submacular hemorrhageZhonghua Yi Xue Za Zhi (Taipei)199962526827710389281
- HeriotWFuther experience in management of submacular hemorrhage with intravitreal tPAProceedings of the Update on Macular SurgerySan Francisco, CA, USAAmerican Academy of Ophthalmology1997
- OhjiMSaitoYHayashiALewisJMTanoYPneumatic displacement of subretinal hemorrhage without tissue plasminogen activatorArch Ophthalmol199811610132613329790631
- HassanASJohnsonMWSchneidermanTEManagement of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacementOphthalmology1999106101900190610519583
- MizutaniTYasukawaTItoYPneumatic displacement of submacular hemorrhage with or without tissue plasminogen activatorGraefes Arch Clin Exp Ophthalmol201124981153115721445629
- FangIMLinYCYangCHYangCMChenMSEffects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degenerationEye (Lond)200923239740617975562
- RosenfeldPJMoshfeghiAAPuliafitoCAOptical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degenerationOphthalmic Surg Lasers Imaging200536433133516156152
- RichRMRosenfeldPJPuliafitoCAShort-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degenerationRetina200626549551116770255
- BashshurZFBazarbachiASchakalAHaddadZAEl HaibiCPNoureddinBNIntravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degenerationAm J Ophthalmol200614211916815245
- StifterEMichelsSPragerFIntravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhageAm J Ophthalmol2007144688689217916314
- SacuSStifterEVecsei-MarlovitsPVManagement of extensive subfoveal haemorrhage secondary to neovascular age-related macular degenerationEye (Lond)20092361404141018756282
- GuthoffRGuthoffTMeigenTGoebelWIntravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degenerationRetina2011311364020921929
- CakirMCekicOYilmazOFPneumatic displacement of acute submacular hemorrhage with and without the use of tissue plasminogen activatorEur J Ophthalmol201020356557120037915
- JohnsonMWOlsenKRHernandezETissue plasminogen activator treatment of experimental subretinal hemorrhageRetina19911122502581925092
- ChenCYHooperCChiuDChamberlainMKariaNHeriotWJManagement of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gasRetina200727332132817460587
- ChawlaSMisraVKhemchandaniMPneumatic displacement and intravitreal bevacizumab: a new approach for management of submacular hemorrhage in choroidal neovascular membraneIndian J Ophthalmol200957215515719237795
- HaslerPWla CourMVillumsenJPneumatic displacement and intravitreal bevacizumab in the management of subretinal haemorrhage caused by choroidal neovascularizationActa Ophthalmol Scand200785557757917559558
- HuangJLiuXWuZXiaoHDustinLSaddaSMacular thickness measurements in normal eyes with time-domain and Fourier-domain optical coherence tomographyRetina200929798098719584656
- KungY-HWuT-THongM-CSheuS-JIntravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhageJ Ocul Pharmacol Ther201026546947420925578
- ShoKTakahashiKYamadaHPolypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristicsArch Ophthalmol2003121101392139614557174
- MarukoIIidaTSaitoMNagayamaDSaitoKClinical characteristics of exudative age-related macular degeneration in Japanese patientsAm J Ophthalmol20071441152217509509
- YoonJSLeeJLeeSCKohHJKimSSKwonOWPolypoidal choroidal vasculopathy in Korean patients with large submacular hemorrhageYonsei Med J200748222523217461520
- HesseLSchmidtJKrollPManagement of acute submacular hemorrhage using recombinant tissue plasminogen activator and gasGraefes Arch Clin Exp Ophthalmol1999237427327710208258
- GomiFSawaMSakaguchiHEfficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathyBr J Ophthalmol2008921707317567661